|
Market Closed -
Euronext Bruxelles
23:55:00 11/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 205.60 EUR | +1.93% |
|
-2.37% | -13.83% |
| 09-11 | AlphaValue/Baader Europe Sees UCB Share Drop as 'Rare Window of Affordability'; Price Target Up | MT |
| 09-10 | UCB: A rare window of affordability |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 45.5B | |||||
| 78.02B | |||||
| 57.4B | |||||
| 57.48B | - | ||||
| 48.81B | |||||
| 32.08B |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
